ANIK Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

SPRZEDAż 109568 min ago

@ $23.63

Wydano: 14 vas. 2024 @ 16:30

Zwrot: 8.91%

Poprzedni sygnał: vas. 13 - 16:30

Poprzedni sygnał: Kupno

Zwrot: 0.60 %

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 19:32):

Stats
Dzisiejszy wolumen	7 731.00
Średni wolumen	79 122.00
Kapitalizacja rynkowa	382.16M
EPS	$0 ( 2024-03-13 )
Następna data zysków	( $-0.190 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.56
ATR14	$0.0480 (0.19%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	Levitz Michael L	Buy	51 682	Stock Option (Right to Buy)
2024-03-15	Levitz Michael L	Buy	21 329	Restricted Stock Unit
2024-03-15	Colleran David	Buy	46 875	Stock Option (Right to Buy)
2024-03-15	Colleran David	Buy	19 345	Restricted Stock Unit
2024-03-15	Nunes Anne	Buy	26 442	Stock Option (Right to Buy)

INSIDER POWER
51.59
Last 100 transactions
Buy: 1 044 875 \| Sell: 338 384

Wolumen Korelacja

Długi: -0.08 (neutral)

Krótki: -0.11 (neutral)

Signal:(36.787) Neutral

Anika Therapeutics Inc Korelacja

10 Najbardziej pozytywne korelacje
RMRM	0.905
BPTH	0.892
GOODN	0.886
RMGC	0.883
MLVF	0.875
BCOV	0.872
ALLT	0.87
WISH	0.868
GOODO	0.868
APTX	0.868

10 Najbardziej negatywne korelacje
PTRS	-0.908
AAON	-0.874
ULBI	-0.866
CORT	-0.859
PXI	-0.855
STEP	-0.842
PSCE	-0.84
TUR	-0.838
GSHD	-0.837
FTXN	-0.837

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Anika Therapeutics Inc Korelacja - Waluta/Towar

0.62
( weak )

0.70
( moderate )

0.00
( neutral )

0.81
( strong )

-0.45
( neutral )

0.00
( neutral )

Anika Therapeutics Inc Finanse

Annual	2023
Przychody:	$166.66M
Zysk brutto:	$103.09M (61.85 %)
EPS:	$-5.64

FY	2023
Przychody:	$166.66M
Zysk brutto:	$103.09M (61.85 %)
EPS:	$-5.64

FY	2022
Przychody:	$156.24M
Zysk brutto:	$93.58M (59.89 %)
EPS:	$-1.020

FY	2021
Przychody:	$147.79M
Zysk brutto:	$82.94M (56.12 %)
EPS:	$0.290

Financial Reports:

No articles found.

Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.